Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019031961) HUMAN MILK OLIGOSACCHARIDE FOR IMPROVING IMMUNE FITNESS
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2019/031961 International Application No.: PCT/NL2017/050532
Publication Date: 14.02.2019 International Filing Date: 11.08.2017
IPC:
A61P 37/00 (2006.01) ,A23L 33/125 (2016.01) ,A61K 31/702 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37
Drugs for immunological or allergic disorders
[IPC code unknown for A23L 33/125]
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
702
Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
Applicants:
N.V. NUTRICIA [NL/NL]; Eerste Stationsstraat 186 2712 HM Zoetermeer, NL
Inventors:
POTAPPEL - VAN 'T LAND, Belinda; NL
VAN DEN ELSEN, Lieke Wilhelmina Johanna; NL
STAHL, Bernd; NL
Agent:
NEDERLANDSCH OCTROOIBUREAU; P.O. Box 29720 2502 LS The Hague, NL
Priority Data:
Title (EN) HUMAN MILK OLIGOSACCHARIDE FOR IMPROVING IMMUNE FITNESS
(FR) OLIGOSACCHARIDE DE LAIT HUMAIN POUR AMÉLIORER LA CONDITION PHYSIQUE IMMUNITAIRE
Abstract:
(EN) The invention concerns the use of fucosylated non-digestible human milk oligosaccharide such as 2` -fucosyllactose, or a composition comprising a fucosylated non-digestible human milk oligosaccharide, for use in improving immune fitness, for use in restoration of immune balance, for use in enhancing vaccine specific immune response in a human subject, wherein the human subject is male.
(FR) L'invention concerne l'utilisation d'un oligosaccharide de lait humain fucosylé non digestible tel que le 2'-fucosyllactose, ou une composition comprenant un oligosaccharide de lait humain fucosylé non digestible, destinée à être utilisée dans l'amélioration de la condition physique immunitaire, destinée à être utilisée dans la restauration de l'équilibre immunitaire, destinée à être utilisée dans l'amélioration de la réponse immunitaire spécifique à un vaccin chez un sujet humain, le sujet humain étant de sexe masculin.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)